Elevated Vascular Cell Adhesion Molecule-1 in AIDS Encephalitis Induced by Simian Immunodeficiency Virus

Total Page:16

File Type:pdf, Size:1020Kb

Elevated Vascular Cell Adhesion Molecule-1 in AIDS Encephalitis Induced by Simian Immunodeficiency Virus American Journal ofPathology, Vol. 141, No. 5, November 1992 Copyright © American Association ofPathologists Short Communication Elevated Vascular Cell Adhesion Molecule-1 in AIDS Encephalitis Induced by Simian Immunodeficiency Virus Vito G. Sasseville,* Walter A. Newman,t nervous system, and this expression may, at least in Andrew A. Lackner, Mary 0. Smith,11 part, influence monocyte and lymphocyte recruit- Niels C. G. Lausen,* Dawson Beallt and ment to the central nervous system during the devel- Douglas J. Ringler* opment of AIDS encephalitis. Moreover, measure- From the Harvard Medical School, New England Regional ment of soluble VCAM-1 in CSF may assist in the Primate Research Center, Southborough, Massachusetts, clinical assessment of animals or people with AIDS. Otsuka America Pharmaceutical, Inc.,t Rockville, Maryland, (AmJPathol 1992, 141:1021-1030) New Mexico State University,* New Mexico Regional Primate Research Laboratory, Holloman Air Force Base, New Mexico, and the University of California,1I California Regional One of the most devastating manifestations of HIV-1 in- Primate Research Center, Davis, California fection involves an inflammatory disease of the central nervous system (CNS), referred to as AIDS encephalitis, AIDS encephalopathy, HIV encephalitis, or AIDS demen- AIDS encephalitis is a common sequela to HIV-1 in- tia complex.1" This disorder is characterized by multifo- fection in humans and simian immunodeficiency vi- cal gliosis and parenchymal infiltrates of multinucleate rus (SlVmac) infection in lenti- macaques. Although giant cells and macrophages.1 2.4 Many of the macro- viral-infected macrophages comprise parenchymal phages comprising these infiltrates contain HIV-1 protein, inflammatory infiltrates in affected brain tissue, the viral nucleic acid transcripts, and mature virions.35 8 In mechanisms responsible for leukocyte trafficking to addition, as these histologic changes are not associated the central nervous system in AIDS are unknown In with secondary opportunistic pathogens, it is believed this study, we investigated the expression of various that HIV encephalitis represents a primary lentiviral dis- endothelial-derived leukocyte adhesion in proteins ease manifestation. SIVmac-induced AIDS encephalitis. Encephalitic Not all patients infected with HIV-1 develop enceph- brains from SIVmac-infected but not un- macaques, alitis. Approximately 50% of patients infected with HIV-1 inflamed brains from other SlVmac-infected ani- have histologic evidence of AIDS encephalitis at the time mals; were found to express abundant vascular cell of postmortem examination.1' 2'49 Similarly, approxi- adhesion molecule-i (VCAM-1) protein on the ma- mately 50% of rhesus monkeys experimentally infected jority of arteriolar, venular, and capillary endothe- with simian immunodeficiency virus (SlVmac) develop lial cells. Soluble VCAM-1 concentrations in cerebro- an encephalitis similar to that seen in humans with spinal fluid (CSF) from encephalitic animals were increased approximately 20-fold above those from Supported by Public Health Service awards Al 29855, Al 25644, RR animals without AIDS encephalitis. Expression of 00168, RR 00169 and 5T32RR07000 from the National Institutes of other endothelial-related adhesion molecules, in- Health. A. Lackner was supported by a Public Health Service special cluding E-selectiny P-selectin, and intercellular adhe- emphasis research career award in laboratory animal science from the sion molecule-I (ICAM-1), was not uniformly asso- National Center for Research Resources (RR 0039). Accepted for publication July 24, 1992. ciated with AIDS encephalitis. Thus, the presence of Address reprint requests to Dr. Douglas J. Ringler, Harvard Medical VCAM-1 in both brain and CSF was uniformly asso- School, New England Regional Primate Research Center, P.O. Box 9102, ciated with SlVmac-induced disease of the central Southborough, MA 01772-9102. 1021 1022 Sasseville et al AJP November 1992, Vol. 141, No. 5 AIDS.""12 SlVmac and HIV-1 share extensive sequence expression of E-selectin and VCAM-1 on resting endot- homology and have similar genomic organization, mor- helium. 19,20'28'38'39 In contrast, ICAM-1 and P-selectin phology, and biologic properties.1315 Most importantly, are basally expressed on endothelium in many tis- SlVmac-infected macaques develop immunodeficiency sues.17'31'36 Inasmuch as leukocyte-endothelial adhe- and a clinical syndrome identical in many ways to AIDS in sion is requisite for vascular extravasation of leuko- humans. Thus, SlVmac-infected rhesus monkeys repre- cytes,40 homing of specific leukocyte cell types to the sent a useful model to study the pathogenesis of HIV CNS may be controlled by different endothelial expres- encephalitis and other AIDS-related sequelae. sion of these leukocyte adhesion molecules. We have previously suggested that in simian AIDS, In this study, we investigated the expression of leuko- the presence of viruses in vivo with replicative potential cyte adhesion molecules in SlVmac-induced AIDS en- for macrophages is essential, but not predictive, for the cephalitis. We found that encephalitic brains from SIV- development of SlVmac-induced AIDS encephalitis.16 mac-infected animals expressed abundant VCAM-1 pro- Thus, both viral and host parameters are likely involved in tein on the majority of parenchymal vessels. In addition, determining which patients ultimately progress to lentivi- concentrations of soluble VCAM-1 (sVCAM-1) in cere- ral-induced disease of the CNS. Understanding the brospinal fluid (CSF) from encephalitic animals were mechanisms responsible for the development of this dis- markedly elevated over those from animals without AIDS order has obvious important consequences. First, thera- encephalitis. These findings underscore the potential rel- peutic intervention studies can be directed to early cel- evance of VCAM-1 expression in the pathogenesis of lular events before clinical disease. Secondly, less inva- AIDS encephalitis. Furthermore, detection of elevated sive means of diagnosis of encephalitis may be possible sVCAM-1 in CSF may assist in the clinical diagnosis of by detecting the earliest host parameters or pathogenetic this manifestation in animals or people with AIDS. mechanisms involved in leukocyte trafficking in the brain. Thirdly, a better understanding of the mechanisms in- volved in AIDS encephalitis will likely broaden our under- Materials and Methods standing of other primary lentiviral disease manifesta- tions. Unfortunately, the sequence of events and mech- Animals and Virus anisms involved in the genesis of this disease remain largely unknown. Brain tissue from 37 rhesus monkeys (Macaca mulatta), HIV- and SlVmac-induced encephalitis share many one barbary macaque (M. sylvana), one pigtail macaque features in common with other inflammatory diseases. (M. nemestrina), and one cynomolgus monkey (M. fas- Leukocytes marginate and adhere to venular endothe- cicularis) was collected at death and used for immuno- lium, extravasate from the vascular lumen, and eventually histochemical analysis. Thirty-four of these animals were collect as perivascular and parenchymal inflammatory in- experimentally infected with SlVmac before death. The filtrates. In a number of inflammatory processes, endo- strain of SlVmac used for experimental infection, survival thelial activation and de novo endothelial production of time, age, and related animal data are contained within novel membrane proteins in the brain17'18 and other tis- Table 1. The procedures associated with the experimen- sues1923 precedes the formation of inflammatory infil- tal infection of many of these macaques with SlVmac trates. Some of these endothelial membrane proteins are have been described in detail previously.14'16'41X5 Ani- cell adhesion molecules, which have been shown to be mals were inoculated either intravenously or intramuscu- involved in the adhesion of leukocytes to cytokine- larly with uncloned SlVmac25i,154346 molecularly stimulated endothelium in vitro.19'2,28 Recent interest cloned SlVmac239,14'47,48 or an uncloned macrophage- has focused on four proteins, designated E-selectin, tropic variant of SlVmac239, termed SlVmac239/31614.16 P-selectin, intercellular adhesion molecule-1 (ICAM-1), (Table 1). All animals were shown to be persistently in- and vascular cell adhesion molecule-1 (VCAM- fected with SlVmac by multiple viral isolations from pe- 1).24 27,2319 These molecules have been shown to differ ripheral blood mononuclear cells, as previously de- in their leukocyte binding repertoire in vitro so that E-se- scribed,46 and/or a rise in serum antibody response lectin selectively promotes endothelial adhesion to poly- against SlVmac proteins.49 morphonuclear cells and memory T cells,27'32 P-selectin Normal brain tissue from five mature rhesus monkeys enhances endothelial attachment to polymorphonuclear and one cynomolgus monkey was also evaluated as a cells,33 VCAM-1 mediates monocyte, lymphocyte, baso- control (Table 1). These monkeys were serologically neg- phil, and eosinophil attachment,19'2426'34,35 whereas ative for SlVmac before death. ICAM-1 promotes the adhesion of all types of leuko- In addition, CSF was collected from 30 SlVmac- cytes.36'37 Differences in basal expression of these pro- infected rhesus monkeys at the time of death by lumbar teins exist, so that there is an absence, or at the most, little or cisternal puncture. All 30 CSF samples were obtained VCAM-1 in AIDS Encephalitis 1023 AJP November 1992, Vol. 141, No.
Recommended publications
  • Thrombokinetics in Giant Cell Arteritis, with Special Reference to Corticosteroid Therapy
    Ann Rheum Dis: first published as 10.1136/ard.38.3.244 on 1 June 1979. Downloaded from Annals of the Rheumatic Diseases, 38, 1979, 244-247 Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy ANNA-LISA BERGSTROM, BENGT-AKE BENGTSSON, LARS-BERTIL OLSSON, BO-ERIC MALMVALL, AND JACK KUTTI From the Departments of Internal Medicine and Infectious Diseases, Eastern Hospital, University of Gothenburg, S-416 85 Gothenburg, Sweden SUMMARY Duplicate platelet survival studies were carried out on 8 patients with giant cell arteritis (GCA), once before the institution of any therapy, and the second time when they were in a com- pletely asymptomatic phase after having received corticosteroid treatment. The time interval be- tween the studies ranged between 5 and 14 months. In the first study the mean peripheral platelet count was 486 ±25 x 109/1 and in the second 326 ±25 x 109/1. The difference between the means was highly significant (P<0 001). The mean life-span of the platelets was normal in the duplicate experiments (6 * 7 ±0 * 3 and 7 *3 ±0 *4 days, respectively). Platelet production rate was significantly (P<0 001) raised in the first experiment but became normal in response to corticosteroid therapy. It is concluded that the thrombocytosis seen in GCA is reactive to the inflammation present in this disease, and it seems reasonable to assume that the reduction in the peripheral platelet count which occurs in response to corticosteroid therapy accurately reflects the clinical improvement of the patient. Thrombocytosis is frequently present in patients Table 1 Eight patients with GCA in whom duplicate platelet sutrvival studies were carried out with untreated giant cell arteritis (GCA) (Olhagen, http://ard.bmj.com/ 1963; Hamrin, 1972; Malmvall and Bengtsson, Patients Age Sex Time interval Maintenance.
    [Show full text]
  • Targeting Innate Immunity to Treat Cancer
    cancers Editorial Targeting Innate Immunity to Treat Cancer Matthew Austin and Harriet Kluger * Yale Cancer Center, Yale School of Medicine, 333 Cedar St, WWW211B, New Haven, CT 06520, USA; [email protected] * Correspondence: [email protected] Received: 14 September 2020; Accepted: 16 September 2020; Published: 23 September 2020 In recent years, it has become clear that the immune system plays a critical role in rejecting malignant cells. Through the complex interplay between multiple cell types from both the adaptive and innate immune systems, immune cells are able to identify and destroy tumor cells. Multiple mechanisms of escape from immune surveillance have been characterized and are being harnessed for therapeutic benefit. Proposed mechanisms include, but are not limited to, alteration of surface antigens [1,2], down-regulation of necessary components for antigen presentation [3], secretion of anti-inflammatory cytokines by tumor cells or cells in the tumor micro-environment [4], and upregulation of expression of immune inhibitory molecules [5]. Drugs that target these immune-evasion mechanisms and successfully re-invigorate the immune response include inhibitors of PD-1, its ligand PDL-1, and CTLA-4, all of which have dramatically revolutionized cancer care [6–8]. Other classes of immune therapies that have been approved by the food and drug administration include CAR-T and natural killer (NK) cellular therapies [9], cytokine therapies [10], oncolytic viruses [11] and dendritic cell therapies, such as sipuleucel-T [12]. Immune checkpoint inhibitors, which are thought to primarily work by activation of cytotoxic T cells [13], are the most widely used; however, they are only active in a subset of cancer patients.
    [Show full text]
  • Immune Cell Migration in Inflammation: Present and Future Therapeutic Targets
    REVIEW DAMPENING INFLAMMATION Immune cell migration in inflammation: present and future therapeutic targets Andrew D Luster1, Ronen Alon2 & Ulrich H von Andrian3 The burgeoning field of leukocyte trafficking has created new and exciting opportunities in the clinic. Trafficking signals are being defined that finely control the movement of distinct subsets of immune cells into and out of specific tissues. Because the accumulation of leukocytes in tissues contributes to a wide variety of diseases, these ‘molecular codes’ have provided new targets for inhibiting tissue-specific inflammation, which have been confirmed in the clinic. However, immune cell migration is also critically important for the delivery of protective immune responses to tissues. http://www.nature.com/natureimmunology Thus, the challenge for the future will be to identify the trafficking molecules that will most specifically inhibit the key subsets of cells that drive disease processes without affecting the migration and function of leukocytes required for protective immunity. The past three decades have witnessed an explosion of knowledge in they deploy to migrate to target tissues? How do trafficking molecules immunology, which is being increasingly ‘translated’ into new thera- regulate effector cell recruitment in vessels and during subsequent trans- pies for seemingly unrelated human pathologies caused by excessive or endothelial and interstitial migration? Which trafficking molecules are misdirected inflammatory responses. Although such diseases can affect promising targets for safe and effective drug inhibition? Which migra- any part of the body, almost all inflammatory conditions are restricted tion-directed drugs might be effective in which disease(s) and why? to particular target organs or tissue components1–3.
    [Show full text]
  • Inflammation and Introduction to Wound Healing
    Inflammation and Introduction to Wound Healing Alan D. Proia, M.D., Ph.D. February 14, 2011 Proia©/DUMC 1 Objectives Understand basic concepts of acute, chronic, and granulomatous inflammation Recognize key leukocytes participating in inflammatory responses Distinguish acute, chronic, and granulomatous inflammation Proia©/DUMC 2 What is Inflammation? Response to injury (including infection) Reaction of blood vessels leads to: » Accumulation of fluid and leukocytes in extravascular tissues Destroys, dilutes, or walls off the injurious agent Initiates the repair process Proia©/DUMC 4 What is Inflammation? Fundamentally a protective response May be potentially harmful » Hypersensitivity reactions to insect bites, drugs, contrast media in radiology » Chronic diseases: arthritis, atherosclerosis » Disfiguring scars, visceral adhesions Proia©/DUMC 5 What is Inflammation? Components of inflammatory response » Vascular reaction » Cellular reaction How: Chemical mediators » Derived from plasma proteins » Derived from cells inside and outside of blood vessels Proia©/DUMC 6 Historical Highlights Celsus, a first century A.D. Roman, listed four cardinal signs of acute inflammation: » Rubor (erythema [redness]): vasodilatation, increased blood flow » Tumor (swelling): extravascular accumulation of fluid » Calor (heat): vasodilatation, increased blood flow » Dolor (pain) Proia©/DUMC 7 Types of Inflammation Acute inflammation Chronic inflammation » Short duration » Longer duration » Edema » Lymphocytes & » Mainly neutrophils macrophages
    [Show full text]
  • Migration Dynamics in Leukocyte Transendothelial Endothelial Actin-Binding Proteins and Actin
    Th eJournal of Brief Reviews Immunology Endothelial Actin-Binding Proteins and Actin Dynamics in Leukocyte Transendothelial Migration Michael Schnoor The endothelium is the first barrier that leukocytes have Ag-1 and macrophage-1 Ag or the b1-integrin very late Ag-4 to overcome during recruitment to sites of inflamed tis- on leukocytes mediate firm adhesion. Subsequently, leukocytes sues. The leukocyte extravasation cascade is a complex reach the site of transmigration by intraluminal crawling. Leu- multistep process that requires the activation of various kocytes can crawl as much as 60 mm in a macrophage-1 Ag/ adhesion molecules and signaling pathways, as well as ac- ICAM-1–dependent fashion before they transmigrate (2). tin remodeling, in both leukocytes and endothelial cells. Transmigration (also known as diapedesis) occurs either trans- Endothelial adhesion molecules, such as E-selectin or cellularly or paracellularly, with the majority of transmigration ICAM-1, are connected to the actin cytoskeleton via events being across paracellular junctions both in vivo and actin-binding proteins (ABPs). Although the contribu- in vitro (3, 4). Finally, leukocytes have to cross pericytes and tion of receptor–ligand interactions to leukocyte extrav- the basement membrane (BM) to conclude extravasation. This asation has been studied extensively, the contribution of occurs through gaps in the pericyte layer that coincide with endothelial ABPs to the regulation of leukocyte adhe- regions of the BM that contain less extracellular matrix proteins sion and transendothelial migration remains poorly un- and, therefore, pose a thinner barrier for the transmigrating derstood. This review focuses on recently published leukocyte (5, 6). All of these steps require cell movement and evidence that endothelial ABPs, such as cortactin, myo- actin cytoskeletal remodeling in both cell types involved.
    [Show full text]
  • Review Article
    J Clin Pathol: first published as 10.1136/jcp.36.7.723 on 1 July 1983. Downloaded from J Clin Pathol 1983;36:723-733 Review article Granulomatous inflammation- a review GERAINT T WILLIAMS, W JONES WILLIAMS From the Department ofPathology, Welsh National School ofMedicine, Cardiff SUMMARY The granulomatous inflammatory response is a special type of chronic inflammation characterised by often focal collections of macrophages, epithelioid cells and multinucleated giant cells. In this review the characteristics of these cells of the mononuclear phagocyte series are considered, with particular reference to the properties of epithelioid cells and the formation of multinucleated giant cells. The initiation and development of granulomatous inflammation is discussed, stressing the importance of persistence of the inciting agent and the complex role of the immune system, not only in the perpetuation of the granulomatous response but also in the development of necrosis and fibrosis. The granulomatous inflammatory response is Macrophages and the mononuclear phagocyte ubiquitous in pathology, being a manifestation of system many infective, toxic, allergic, autoimmune and neoplastic diseases and also conditions of unknown The name "mononuclear phagocyte system" was aetiology. Schistosomiasis, tuberculosis and leprosy, proposed in 1969 to describe the group of highly all infective granulomatous diseases, together affect phagocytic mononuclear cells and their precursors more than 200 million people worldwide, and which are widely distributed in the body, related by http://jcp.bmj.com/ granulomatous reactions to other irritants are a morphology and function, and which originate from regular occurrence in everyday clinical the bone marrow.' Macrophages, monocytes, pro- histopathology. A knowledge of the basic monocytes and their precursor monoblasts are pathophysiology of this distinctive tissue reaction is included, as are Kupffer cells and microglia.
    [Show full text]
  • Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis
    biomedicines Review Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis Thijs J. Sluiter 1,2 , Jaap D. van Buul 3 , Stephan Huveneers 4, Paul H. A. Quax 1,2 and Margreet R. de Vries 1,2,* 1 Department of Vascular Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; [email protected] (T.J.S.); [email protected] (P.H.A.Q.) 2 Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands 3 Sanquin Research and Landsteiner Laboratory, Leeuwenhoek Centre for Advanced Microscopy, Swammerdam Institute for Life Sciences, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] 4 Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Location AMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; [email protected] * Correspondence: [email protected]; Tel.: +31-(71)-526-5147 Abstract: The vascular endothelium is a highly specialized barrier that controls passage of fluids and migration of cells from the lumen into the vessel wall. Endothelial cells assist leukocytes to extravasate and despite the variety in the specific mechanisms utilized by different leukocytes to cross different vascular beds, there is a general principle of capture, rolling, slow rolling, arrest, crawling, and ultimately diapedesis via a paracellular or transcellular route. In atherosclerosis, the barrier function of the endothelium is impaired leading to uncontrolled leukocyte extravasation and Citation: Sluiter, T.J.; van Buul, J.D.; vascular leakage. This is also observed in the neovessels that grow into the atherosclerotic plaque Huveneers, S.; Quax, P.H.A.; de Vries, leading to intraplaque hemorrhage and plaque destabilization.
    [Show full text]
  • Biomaterials and the Foreign Body Reaction: Surface Chemistry Dependent Macrophage Adhesion, Fusion, Apoptosis, and Cytokine Production
    BIOMATERIALS AND THE FOREIGN BODY REACTION: SURFACE CHEMISTRY DEPENDENT MACROPHAGE ADHESION, FUSION, APOPTOSIS, AND CYTOKINE PRODUCTION by JACQUELINE ANN JONES Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: James Morley Anderson, M.D., Ph.D. Department of Biomedical Engineering CASE WESTERN RESERVE UNIVERSITY May, 2007 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Copyright © 2007 by Jacqueline Ann Jones All rights reserved iii Dedication This work is dedicated to… My ever loving and ever supportive parents: My mother, Iris Quiñones Jones, who gave me the freedom to be and to dream, inspires me with her passion and courage, and taught me the true meaning of friendship. My father, Glen Michael Jones, a natural-born teacher who taught me to be an inquisitive student of life, inspires me with his strength and perseverance, and gave me his kind, earnest heart that loves deeply and always
    [Show full text]
  • Malignant Tenosynovial Giant Cell Tumor: the True €Œsynovial Sarcoma?€• a Clinicopathologic, Immunohistochemical
    Modern Pathology (2019) 32:242–251 https://doi.org/10.1038/s41379-018-0129-0 ARTICLE Malignant Tenosynovial Giant Cell Tumor: The True “Synovial Sarcoma?” A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes 1 2 1 1 1 3 Alyaa Al-Ibraheemi ● William Albert Ahrens ● Karen Fritchie ● Jie Dong ● Andre M. Oliveira ● Bonnie Balzer ● Andrew L. Folpe1 Received: 5 July 2018 / Revised: 31 July 2018 / Accepted: 1 August 2018 / Published online: 11 September 2018 © United States & Canadian Academy of Pathology 2018 Abstract We present our experience with ten well-characterized malignant tenosynovial giant cell tumors, including detailed immunohistochemical analysis of all cases and molecular cytogenetic study for CSF1 rearrangement in a subset. Cases occurred in 7 M and 3 F (mean age: 52 years; range: 26–72 years), and involved the ankle/foot (n = 1), finger/toe (n = 3), wrist (n = 1), pelvic region (n = 3), leg (n = 1), and thigh (n = 1). There were eight primary and two secondary malignant 1234567890();,: 1234567890();,: tenosynovial giant cell tumors. Histologically, all cases showed definite areas of typical tenosynovial giant cell tumor. The malignant areas varied in appearance. In some cases, isolated malignant-appearing large mononuclear cells with high nuclear grade and mitotic activity were identified within otherwise-typical tenosynovial giant cell tumor, as well as forming larger masses of similar-appearing malignant cells. Occasionally, these nodules of malignant large mononuclear cells showed transition to pleomorphic spindle cell sarcoma, with varying degrees of collagenization and myxoid change. One malignant tenosynovial giant cell tumor was composed of sheets of monotonous large mononuclear cells with high nuclear grade, growing in a hyalinized, osteoid-like matrix, with areas of heterologous osteocartilaginous differentiation.
    [Show full text]
  • The Pathogenesis of Giant Cell Arteritis: Morphological Aspects
    The morphology of GCA / C. Nordborg et al. The pathogenesis of giant cell arteritis: Morphological aspects C. Nordborg1, E. Nordborg2, V. Petursdottir1 1Department of Pathology, 2Department of ABSTRACT in GCA. When studying V-beta families Rheumatology, Sahlgrenska University The light-microscopic, electron-micro- of the T-cell infiltrate with flow cyto- Hospital, Göteborg, Sweden. scopic and immunocytochemical charac- metry, Schaufelberger et al. found that These studies were supported by grants teristics of giant cell arteritis (GCA) the infiltrating lymphocytes are polyclo- from the Göteborg Medical Society, the have been investigated in a number of nal (3). On the other hand, Weyand et Swedish Heart-Lung Foundation, the studies on temporal arteries. Arterial al. (4) demonstrated the identical clonal Swedish Rheumatism Association, Rune atrophy and calcification of the internal expansion of a small proportion of the och Ulla Amlöfs Stiftelse and Syskonen elastic membrane appear to be prere- T-lymphocytes in separate segments of Holmströms Donationsfond. quisites for the evolution of the inflam- the same artery, which indicates antigen Please address correspondence and reprint matory process. Foreign body giant cells stimulation. A correlation between va- requests to: Claes Nordborg, Department form close to calcifications, apparently rious infections and the onset of GCA of Pathology, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. without connection with other inflam- has been reported; it has been speculated E-mail: [email protected] matory cells and probably by the fusion that infectious disorders might trigger the of modified vascular smooth muscle inflammatory process (5). Zoster-vari- Clin Exp Rheumatol 2000: 18 (Suppl. 20): cells.
    [Show full text]
  • In Vivo Studies of the Foreign Body Reaction to Biomedical
    IN VIVO STUDIES OF THE FOREIGN BODY REACTION TO BIOMEDICAL POLYMERS by Junghoon Yang Submitted in partial fulfillment of the requirements For the degree of Master of Science Thesis Adviser: Dr. James M. Anderson Department of Biomedical Engineering CASE WESTERN RESERVE UNIVERSITY May, 2013 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Junghoon Yang candidate for the Master of Science in Biomedical Engineering. Chair of the Committee Dr. James M. Anderson Members of the Committee Dr. Horst von Recum Dr. Roger Marchant Date of Defense: March 7th, 2013 Table of Contents List of Tables………………………………………………………………………..ii List of Figures……………………………………………………………………….iv Abstract……………………………………………………………………………..vii Chapter I: Introduction………………………………………………………………1 Chapter II: Quantitative Versus Qualitative Assessment of the Extent of Foreign Body Reaction (Percent Fusion, Cell Density, and Nuclei Density)……...7 Materials and Methods……………………………………………………….11 Results………………………………………………………………………...31 Discussion……………………………………………………………………..65 References…………………………………………………………………….70 Chapter III: Controlling Fibrous Capsule Formation through Long-Term Down-Regulation of Collagen Type 1 (COL1A1) Expression by Nanofiber- Mediated siRNA Gene Silencing……………………………………………………….73 Materials and Methods…………………………………………………………75 Results…………………………………………………………………………..79 Discussion……………………………………………………………………….84 i List of Tables Chapter II Table 1. Animal Phenotype Table Indicating Strain, General Information, Specific Traits, and References………………………………………………………….9 Table 2. Quantitative Percent Fusion for PEU with Timepoints 14, 21, and 28 Days…..37 Table 3. Average Cell Density for PEU with Timepoints 14, 21, and 28 Days…………39 Table 4. Average Nuclei Density for PEU with Timepoints 14, 21, and 28 Days………41 Table 5. Qualitative Normalized Average Grading for PEU with Timepoints 14, 21, and 28 Days…………………………………………………………43 Table 6. Quantitative Percent Fusion for PET with Timepoints 14, 21, 28 Days ………45 Table 7.
    [Show full text]
  • Giant Cell Arteritis
    GIANT CELL ARTERITIS What is giant cell arteritis (GCA)? Giant cell arteritis (GCA) is a form of vasculitis—a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage vital organs and tissues. Also called temporal arteritis, GCA typically affects the arteries in the neck and scalp, especially the temples. It can also affect the aorta and its large branches to the head, arms and legs. GCA is the most common form of vasculitis in adults over the age of 50. The most common symptoms of GCA include persistent, throbbing headaches, tenderness of the temples and scalp, jaw pain, fever, joint pain, and vision problems. Early treatment is vital to prevent serious complications such as blindness or stroke. GCA is typically treated with high doses of corticosteroids such as prednisone, sometimes in combination with other medications that suppress the immune system. Prompt treatment usually relieves symptoms, however GCA is a chronic condition with periods of relapse and remission, so ongoing medical care is usually necessary. Patients with GCA may also have symptoms of polymyalgia rheumatica (PMR), a closely related inflammatory disorder. Causes The cause of GCA is not yet fully understood by researchers. Vasculitis is classified as an autoimmune disorder—a disease which occurs when the body’s natural defense system mistakenly attacks healthy tissues. Researchers believe a combination of factors may trigger the inflammatory process. Studies have linked genetic factors, infectious agents, and a prior history of cardiovascular disease to the development of GCA. Who gets GCA? GCA is the most common form of vasculitis in older adults, affecting people over 50 years of age, with an average onset of 74 years of age.
    [Show full text]